Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
BioCryst Pharmaceuticals Inc. logo

BioCryst Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

6.15
 
USD
  
-0.04
  
(-0.65%)
Optionable: Yes  Market Cap: 1,277 M  90-day average vol: 3,563,241

Previous close: 6.19  Open: 6.11  Bid: 6.07  Ask: 6.28
52 week range    
4.03   
   8.96
Peers   
RGEN / 
SRPT / 
NNVC / 
NVAX / 
GILD / 
CLDX / 
GSK / 
EBS / 
Last updated: Thursday 30th May 2024
49
MarketXLS Rank
40
Value
69
Technical
39
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CLDX

1 B-17.331.4

CVM

0 B-6.55.71

EBS

3 B11.145.67

GILD

0.044486 B11.763.76

GSK

NNVC

0 B-2.92.39

NVAX

7 B-6.394.8

RGEN

11 B94.4201.39

SRPT

6 B-11.775.95
Financials

BCRX Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquiredInProcessRnDIncome40 M
Basic EPS from continuing operations-0.98-0.94-1.09-1.03-1.33-1.18
Basic EPS total-0.25-0.98-0.94-1.09-1.03-1.33-1.18
Basic weighted shares outstanding31 M172 M74 M84 M103 M116 M168 M178700.0186 M192 M
Cost of sales-1000.0-1 M-2 M-1 M4 M2 M7 M6 M4 M
Depreciation-177000.0-180000.0-483000.0-704000.0-770000.0724000.0748000.0777000.01 M2 M
DepreciationAndAmortization-177000.0-180000.0-483000.0-704000.0-770000.0724000.0748000.0777000.01 M2 M
Diluted EPS total-0.68-0.59-0.75-0.78-0.98-0.94-1.09-1.03-1.33-1.18
Diluted normalized net income/share-1.03-1.33-1.18
Diluted weighted shares outstanding67 M73 M74 M84 M103 M116 M167 M179 M186 M192 M
Earnings from equity interest11 M
EarningsFromEquityInterestNetOfTax11 M
GainOnSaleOfSecurity5 M1 M-843000.0-821000.00.0
GeneralAndAdministrativeExpense-633000.0-664000.0-721000.0-617000.030 M37 M68 M119 M159 M214 M
Gross operating profit27 M47 M24 M-1 M21 M45 M16 M150 M264 M327 M
ImpairmentOfCapitalAssets2 M
Income before tax-21 M-43 M-55 M-66 M-101 M-111 M-183 M-182 M-244 M-226 M
Income taxes-22000.0-1 M-1 M-71 M-18000.0-2 M-3 M2 M3 M310000.0
Interest income93000.0535000.0793000.01 M2 M2 M
InterestExpenseNonOperating5 M5 M6 M9 M9 M12 M15 M59 M99 M108 M
MiscOtherSpecialCharges25 M-2 M56 M-29 M
Net income from total operations-21 M-43 M-55 M-66 M-101 M-109 M-183 M-184 M-247 M-227 M
NetIncomeCommonStockholders-21 M-43 M-55 M-66 M-101 M-109 M-192 M-184 M-247 M-227 M
NetIncomeContinuousOperations-21 M-43 M-55 M-66 M-101 M-109 M-183 M-184 M-247 M-227 M
NetIncomeFromOtherGainsLosses2 M9 M
NetNonOperatingInterestIncomeExpense-5 M-5 M-6 M-8 M-7 M-12 M-15 M-59 M-99 M-108 M
Operating income-32 M-39 M-49 M-83 M-94 M-99 M-175 M-178 M-148 M-104 M
Operating income before depreciation (EBITDA)-15 M-37 M-47 M-55 M-90 M-97 M-164 M-68 M-146 M-127 M
OperatingExpense59 M86 M73 M81 M115 M145 M191 M328 M413 M430 M
Other income net-16 M-1 M843000.0-24 M2 M-56 M29 M
OtherGandA-633000.0-664000.0-721000.0-617000.030 M37 M68 M119 M159 M214 M
OtherOperatingExpenses121000.0528000.0402000.0560000.0471000.0375000.0-1 M-1 M-4 M-825000.0
PromotionAndAdvertising-290000.0-103000.00.07 M6 M15 M14 M
RentAndLandingFees-633000.0-664000.0-721000.0-617000.00.0
Research & development expense52 M73 M61 M67 M85 M107 M123 M209 M253 M217 M
ResearchExpense52 M73 M61 M67 M85 M107 M123 M209 M253 M217 M
Revenue per share-439000.0-439000.0-558000.0-876000.0-885000.01 M2 M816000.01 M
SalariesAndWages-10 M-10 M-8 M-13 M
Selling Gen & administrative expense7 M13 M11 M14 M30 M37 M68 M119 M159 M214 M
SellingAndMarketingExpense7 M13 M11 M14 M7 M6 M15 M14 M
SellingExpense7 M13 M11 M14 M
Special income/charges-2 M
Total Income available for interest expense (EBIT)-16 M-38 M-49 M-57 M-92 M-99 M-168 M-123 M-145 M-118 M
Total common shares outstanding72 M74 M74 M99 M110 M154 M177 M185 M188 M206 M
Total net income-21 M-43 M-55 M-66 M-101 M-109 M-183 M-184 M-247 M-227 M
Total ordinary shares206 M206 M206 M206 M206 M206 M206 M206 M206 M206 M
Total revenues27 M48 M26 M25 M21 M49 M18 M157 M271 M331 M
TotalExpenses59 M85 M70 M80 M115 M148 M192 M335 M419 M435 M
TotalRevenue33000.06 M2 M25 M21 M49 M18 M157 M271 M331 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University